Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGFILGRASTIM-PBBK: 51 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
51
Total FAERS Reports
17 (33.3%)
Deaths Reported
15
Hospitalizations
51
As Primary/Secondary Suspect
Prescription
Status

FDA Application: 761084 ·

First Report: 20230101 · Latest Report: 20250412

What Are the Most Common PEGFILGRASTIM-PBBK Side Effects?

#1 Most Reported
No adverse event
11 reports (21.6%)
#2 Most Reported
Death
11 reports (21.6%)
#3 Most Reported
Needle issue
8 reports (15.7%)

All PEGFILGRASTIM-PBBK Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Death 11 21.6% 11 3
No adverse event 11 21.6% 0 0
Needle issue 8 15.7% 0 0
Hospitalisation 7 13.7% 2 7

Who Reports PEGFILGRASTIM-PBBK Side Effects? Age & Gender Data

Gender: 35.7% female, 64.3% male. Average age: 62.2 years. Most reports from: US. View detailed demographics →

Is PEGFILGRASTIM-PBBK Getting Safer? Reports by Year

YearReportsDeathsHosp.
2023 2 1 2
2024 9 4 2
2025 8 4 4

View full timeline →

What Is PEGFILGRASTIM-PBBK Used For?

IndicationReports
Product used for unknown indication 40

Official FDA Label for PEGFILGRASTIM-PBBK

Official prescribing information from the FDA-approved drug label.